This stock needs some pr bad I know they are trying to aquire a chinese company but I have heard nothing from the company once they announce the buy the stock should jump still holding
Nothing more than what was initially spoken of by the CEO. What I missed in the interview was the start of clinical trials. I heard first quarter but did not pay attention to 2009. Not sure how I missed that, but unless someone else knows different I do not see any interest until the trials are at least underway if not completed.
Market Data 
Markets 
AI
